drugset / Trial / NCT06492655
To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, open-label, single dose, crossover, phase 1 trial to evaluate the food effect on pharmacokinetic profiles and safety of CKD-383 in healthy volunteers
Timeline
- Start
- 2024-07-04
- Primary completion
- 2024-08-01
- Completion
- 2024-08-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | — | Oral |
| Subject | Lobeglitazone | Small molecule | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |